(4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide

C27H29N7O6 — CID 90718730

IUPAC(4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide
SMILESC[C@H](NC(=O)[C@@H]1CCCN2C(=O)CC[C@H](NC(=O)Nc3ccc(Oc4ccccc4)cc3)C(=O)N12)C(=O)C=[N+]=[N-]
InChIInChI=1S/C27H29N7O6/c1-17(23(35)16-29-28)30-25(37)22-8-5-15-33-24(36)14-13-21(26(38)34(22)33)32-27(39)31-18-9-11-20(12-10-18)40-19-6-3-2-4-7-19/h2-4,6-7,9-12,16-17,21-22H,5,8,13-15H2,1H3,(H,30,37)(H2,31,32,39)/t17-,21-,22-/m0/s1
InChIKeyRJNOAGIAOAYSIZ-HSQYWUDLSA-N
MW547.57 g/mol
LogP1.87
Rot. Bonds8

About (4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide

(4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide (PubChem CID 90718730) has the molecular formula C27H29N7O6 and a molecular weight of 547.57 g/mol. Its IUPAC name is (4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide.

Molecular Properties

Compound Name(4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide
PubChem CID90718730
Molecular FormulaC27H29N7O6
Molecular Weight547.57 g/mol
Exact Mass547.22
IUPAC Name(4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide
SMILESC[C@H](NC(=O)[C@@H]1CCCN2C(=O)CC[C@H](NC(=O)Nc3ccc(Oc4ccccc4)cc3)C(=O)N12)C(=O)C=[N+]=[N-]
InChIInChI=1S/C27H29N7O6/c1-17(23(35)16-29-28)30-25(37)22-8-5-15-33-24(36)14-13-21(26(38)34(22)33)32-27(39)31-18-9-11-20(12-10-18)40-19-6-3-2-4-7-19/h2-4,6-7,9-12,16-17,21-22H,5,8,13-15H2,1H3,(H,30,37)(H2,31,32,39)/t17-,21-,22-/m0/s1
InChIKeyRJNOAGIAOAYSIZ-HSQYWUDLSA-N
XLogP1.87
TPSA173.55 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms40
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500547.57
LogP ≤ 51.87
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_3', 'substructure': 'N/A'}

Analyze (4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide?
The IUPAC name of (4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide (CID 90718730) is (4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide.
What is the SMILES notation for (4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide?
The canonical SMILES for (4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide is C[C@H](NC(=O)[C@@H]1CCCN2C(=O)CC[C@H](NC(=O)Nc3ccc(Oc4ccccc4)cc3)C(=O)N12)C(=O)C=[N+]=[N-].
What is the InChIKey of (4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide?
The InChIKey is RJNOAGIAOAYSIZ-HSQYWUDLSA-N. The full InChI is InChI=1S/C27H29N7O6/c1-17(23(35)16-29-28)30-25(37)22-8-5-15-33-24(36)14-13-21(26(38)34(22)33)32-27(39)31-18-9-11-20(12-10-18)40-19-6-3-2-4-7-19/h2-4,6-7,9-12,16-17,21-22H,5,8,13-15H2,1H3,(H,30,37)(H2,31,32,39)/t17-,21-,22-/m0/s1.
What are the key properties of (4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide?
(4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide has a molecular weight of 547.57 g/mol, XLogP of 1.87, 8 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (4S,7S)-N-[(2S)-4-diazo-3-oxobutan-2-yl]-6,10-dioxo-7-[(4-phenoxyphenyl)carbamoylamino]-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide is sourced from PubChem (CID 90718730), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).